ABOUT DR. ROBIN
Dr. Robin has been dedicated to the Mid-Atlantic region for over two decades. He is a Chicago native receiving his undergraduate training at Yale University and his medical schooling at Tufts University School of Medicine. His fellowship in glaucoma was at the Wilmer Institute, Johns Hopkins University. He is a clinical professor of ophthalmology at the University of Maryland and an adjunct clinical professor for the department of veteran affairs Maryland Health Care System. He is also both an associate professor of international health at the Bloomberg School of Public Health, Johns Hopkins University, and Ophthalmology at the Wilmer Institute at Johns Hopkins University. He was on the editorial board of Graefes Archiv of Ophthalmology and former editor-in-chief of Vision and Aging and editor-in-chief of Glaucoma Management News and currently on the editorial board of Ophthalmologica. He has authored more than 160 papers that have appeared in peer-review journals and has been an invited lecturer on all continents.
He has delivered the Janice Kushner Memorial Lecture for the International Glaucoma Association in London. He is a founding member of the American Glaucoma Society and the Indian Glaucoma Society. He is a member of the American Ophthalmological Society, an exclusive honorary society, requiring an original thesis for admission. He is also a member of the Glaucoma Research Society, a limited society of 100 leading glaucoma specialist throughout the world. He was selected in 2002 & 2007 to be one of Baltimore's top ophthalmologists by Baltimore Magazine and received the 2004 & 2005American Glaucoma Society's nominee for the prestigious American Academy of Ophthalmology's Humanitarian Award which he received in 2005. He is one of the best doctors in Maryland from 2005-2007.
During 1978, a month with Dr. Norval Christy in Taxila, Pakistan, changed his life. He realized the magnitude of preventable blindness in less developed nations and began seeking methods of eliminating needless blindness. This led him to research that could help better preserve vision.
He has been a pioneer in laser research for glaucoma. He was instrumental in both the development of Nd:YAG laser iridotomy, a portable ND:YAG laser, and creating a better definition of the utility and limitations of laser trabeculoplasty. Surgical intervention in developing nations has also been one of Dr. Robin's interests. He has been involved with seminal research into the use of intraocular lens, mitomycin, and phacoemulsification in developing nations. He is currently one of the principal investigators of the Aravind Comprehensive Eye Survey, a population based epidemiologic study of over 17,000 individuals in Southern India.
He has worked with new surgical techniques including the AquaFlow and Viscocanalostomy. He has helped develop faster and better testing for the detection and tracking of glaucoma. Finally, Dr. Robin has been a major leader in the pharmacologic therapy for glaucoma. He has been a researcher on many of the currently used medications for glaucoma and has had pivotal roles in the development of apraclonidine, brimonidine, brinzolamide, dorzolamide, latanoprost, travoprost, and levobunolol.
He has been a consultant to many including the following: Alcon, Allergan, Coherent, Humphrey, IOLAB, Ista, Laser Diagnostics, Merck, Oculus, Vision Rx, Pharmacia, Pfizer, and Zeiss.
Copyright held by Dr. Alan L. Robin ©2006.
No information on this website may be copied without prior permission from Dr. Robin.